| View |
|
DR-XY40977
|
Metformin Hydrochloride
|
Glyformet
|
850 mg
|
Film-Coated Tablet
|
Oral Hypoglycemic (Biguanide)
|
Lloyd Laboratores, Inc.
|
Philippines
|
Automatic Renewal
|
07 April 2022
|
21 June 2027
|
| View |
|
DR-XY40991
|
Cefuroxime (as Axetil)
|
Cefurex
|
500 mg
|
Film-Coated Tablet
|
Antibacterial (Cephalosporin)
|
Lloyd Laboratories,Inc.
|
Philippines
|
Renewal
|
28 April 2022
|
28 June 2027
|
| View |
|
DR-XY40994
|
Zinc Sulfate
|
Equisine Relief
|
0.25% w/v
|
Ophthalmic Drops
|
Ocular Decongestant
|
Duopharma (M) Sdn. Bhd.
|
Malaysia
|
-
|
10 May 2022
|
04 July 2027
|
| View |
|
DR-XY41002
|
Omeprazole
|
Meprazol
|
20 mg
|
Capsule
|
Proton Pump Inhibitor
|
The United Drug (1996) Co., Ltd.
|
Thailand
|
Renewal
|
19 April 2022
|
29 June 2027
|
| View |
|
DR-XY41003
|
Boric Acid + Borax
|
Equisine Regular
|
1% / 0.25%
|
Ophthalmic Drops
|
Lubricant
|
Duopharma (M) Sdn. Bhd.
|
Malaysia
|
Renewal
|
28 April 2022
|
04 July 2027
|
| View |
|
DR-XY41011
|
Salbutamol (As Sulfate)
|
Ventol
|
100 mcg
|
Metered Dose Inhaler
|
Selective beta-2-adrenoreceptor agonist
|
Yangzhou No. 3, Pharmaceutical Co., Ltd.
|
China
|
Renewal
|
14 June 2022
|
09 July 2027
|
| View |
|
DR-XY41012
|
Aceclofenac
|
Dolowin SR
|
200 mg
|
Sustained Release Tablet
|
Non-Steroidal Anti-inflammatory Drug /NSAID ( Acetic Acid derivatives and related Substance )
|
Micro Labs Limited
|
India
|
Renewal
|
07 April 2022
|
09 July 2027
|
| View |
|
DR-XY41018
|
Losartan Potassium
|
Zyltan 50
|
50mg
|
Tablet
|
Angiotensin-II-Antagonists
|
Troikaa Pharmaceuticals Ltd.
|
India
|
Renewal
|
23 May 2022
|
09 July 2027
|
| View |
DR-XY41019_PI_01.pdf
|
DR-XY41019
|
Paclitaxel
|
Paclitex
|
6mg/Ml (30mg/5mL)
|
Solution for Injection
|
Antineoplastic
|
Laboratorio Kemex S.A.
|
Argentina
|
Renewal
|
20 May 2022
|
09 July 2027
|
| View |
|
DR-XY41025
|
Propacetamol Hydrochloride
|
Aldocet
|
1 g
|
Powder For Injection (IM/IV)
|
-
|
Standard Chem. & Pharm. Co., Ltd.
|
Taiwan
|
-
|
27 August 2020
|
14 August 2025
|
| View |
|
DR-XY41031
|
Levobupivacaine (As Hydrochloride)
|
Chirocaine
|
5 mg/mL
|
Solution for Injection (Epidural, Intrathecal,
Peripheral, Local Infiltration and Peribulbar Block)
|
Local Anaesthetic (Amide)
|
Curida AS
|
Norway
|
Monitored Release
|
20 April 2022
|
05 July 2025
|
| View |
|
DR-XY41044
|
Iron+ Zinc +Folic Acid+ Cyanocobalamin
|
Aminofer Fa
|
30 mg/ 10 mg/ 1.5 mg/ 15 mcg
|
Tablet
|
Antianemic
|
Premier Nutraceuticals Pvt. Ltd.
|
India
|
Automatic Renewal
|
28 February 2022
|
16 July 2027
|
| View |
|
DR-XY41060
|
Aciclovir
|
ZYLOVIR
|
800 mg
|
Tablet
|
Antiviral (Nucleoside and nucleotide excl. reverse transcriptase inhibitor)
|
U Square Lifescience Pvt. Ltd
|
India
|
Renewal
|
25 August 2022
|
20 July 2027
|
| View |
|
DR-XY41068
|
Ephedrine Sulfate
|
Fedrin
|
30 mg/mL
|
Solution For Injection (I.M./I.V.)
|
Sympathomimetics (Alpha- and beta-adrenoreceptor agonists)
|
Geofman Pharmaceuticals
|
Pakistan
|
Renewal
|
31 May 2022
|
18 July 2027
|
| View |
|
DR-XY41075
|
Cefixime (As Trihydrate)
|
Septipan
|
400 mg
|
Capsule
|
ANTIBACTERIAL (CEPHALOSPORINS)
|
Geofman Pharmaceuticals
|
Pakistan
|
Renewal
|
09 June 2022
|
24 July 2027
|
| View |
|
DR-XY41076
|
Simvastatin
|
Simvastin
|
40 mg
|
Film-Coated Tablet
|
HMG-CoA Reductase Inhibitor
|
Geofman Pharmaceuticals
|
Pakistan
|
Automatic Renewal
|
05 July 2022
|
24 July 2027
|
| View |
|
DR-XY41080
|
Diazepam
|
Vexepam
|
5 mg
|
Tablet
|
Anxiolytic
|
Mercury Laboratories Ltd.
|
india
|
Automatic Renewal
|
07 March 2022
|
26 July 2027
|
| View |
|
DR-XY41081
|
Diazepam
|
Vexepam
|
10 mg
|
Tablet
|
Anxiolytic
|
Mercury Laboratories Ltd.
|
India
|
Automatic Renewal
|
03 March 2022
|
26 July 2027
|
| View |
|
DR-XY41086
|
Co-Amoxiclav
|
Clavoxel-Bid
|
457 mg per 5 mL
|
Powder For Suspension
|
Antibacterial (Penicillin/Beta-Lactamse Inhibitor)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
26 May 2022
|
26 July 2027
|
| View |
|
DR-XY41090
|
Cefuroxime (As Axetil)
|
Zefur
|
125 mg/5 Ml
|
Granules for suspension
|
Antibacterial (Cephalosporin)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
21 June 2022
|
01 August 2027
|